{ "x402Version": 2, "id": 39590, "slug": "39590", "resource": "https://api.magentlab.com/api/calc/hfa_icos_her2", "description": "Lyon 2020 HFA-ICOS baseline cardiovascular risk before HER2-targeted therapy (trastuzumab and related agents). Very high, high, medium, or low from published factors plus Medium 1/2 points; expert-opinion cardiotoxicity guide <2% / 2-9% / 10-19% / >=20%. Concurrent anthracycline is High; sequential anthracycline before HER2 is Medium 1. Deterministic published classification with citation; not a treatment order. magent does not measure LVEF or biomarkers.", "type": "http", "serviceName": "magent", "resourceType": "Agent Service", "accepts": [ { "scheme": "exact", "network": "eip155:8453", "payTo": "0x836Be278f1739fB4308091cD1852F7971Bc19Ee2", "asset": "0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913", "amount": "5000", "amountUsd": 0.005, "maxTimeoutSeconds": 600 } ], "outputSchema": { "properties": { "example": { "type": "object" }, "type": { "type": "string" } }, "required": [ "type" ], "type": "object" }, "extensions": { "bazaar": { "info": { "iconUrl": "https://api.magentlab.com/favicon.ico", "input": { "body": { "items": [ { "age_years": 50, "anthracycline_before_her2": false, "arrhythmia": false, "ckd": false, "concurrent_anthracycline_and_her2": false, "current_or_significant_smoker": false, "diabetes": false, "elevated_bnp": false, "elevated_troponin": false, "heart_failure_or_cardiomyopathy": false, "hypertension": false, "lvef_percent": 60, "mi_or_cabg": false, "obesity": false, "prior_left_chest_or_mediastinal_rt": false, "prior_remote_anthracycline": false, "prior_trastuzumab_cardiotoxicity": false, "severe_valvular_heart_disease": false, "stable_angina": false }, { "age_years": 50, "anthracycline_before_her2": false, "arrhythmia": false, "ckd": false, "concurrent_anthracycline_and_her2": false, "current_or_significant_smoker": false, "diabetes": false, "elevated_bnp": false, "elevated_troponin": false, "heart_failure_or_cardiomyopathy": false, "hypertension": false, "lvef_percent": 60, "mi_or_cabg": false, "obesity": false, "prior_left_chest_or_mediastinal_rt": false, "prior_remote_anthracycline": false, "prior_trastuzumab_cardiotoxicity": false, "severe_valvular_heart_disease": false, "stable_angina": false } ] }, "method": "POST", "type": "http" }, "output": { "example": { "count": 2, "items": [ { "age_years": 50, "anthracycline_before_her2": false, "cardiotoxicity_guide": "<2%", "citation": { "authors": "Lyon AR, Dent S, Stanway S, et al.", "doi": "10.1002/ejhf.1920", "id": "lyon-2020", "pmid": "32458582", "source": "Eur J Heart Fail. 2020;22(11):1945-1960", "title": "Baseline cardiovascular risk assessment in cancer patients scheduled to receive cardiotoxic cancer therapies: a position statement and new risk assessment tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in collaboration with the International Cardio-Oncology Society" }, "components": [ { "factor": "heart_failure_or_cardiomyopathy", "points": 0, "present": false }, { "factor": "prior_trastuzumab_cardiotoxicity", "points": 0, "present": false }, { "factor": "mi_or_cabg", "points": 0, "present": false }, { "factor": "stable_angina", "points": 0, "present": false }, { "factor": "severe_valvular_heart_disease", "points": 0, "present": false }, { "factor": "lvef_lt_50", "points": 0, "present": false, "value": 60 }, { "factor": "age_ge_80", "points": 0, "present": false, "value": 50 }, { "factor": "concurrent_anthracycline_and_her2", "points": 0, "present": false }, { "factor": "lvef_50_54", "points": 0, "present": false, "value": 60 }, { "factor": "arrhythmia", "points": 0, "present": false }, { "factor": "elevated_troponin", "points": 0, "present": false }, { "factor": "elevated_bnp", "points": 0, "present": false }, { "factor": "age_65_79", "points": 0, "present": false, "value": 50 }, { "factor": "prior_remote_anthracycline", "points": 0, "present": false }, { "factor": "prior_left_chest_or_mediastinal_rt", "points": 0, "present": false }, { "factor": "hypertension", "points": 0, "present": false }, { "factor": "diabetes", "points": 0, "present": false }, { "factor": "ckd", "points": 0, "present": false }, { "factor": "anthracycline_before_her2", "points": 0, "present": false }, { "factor": "current_or_significant_smoker", "points": 0, "present": false }, { "factor": "obesity", "points": 0, "present": false } ], "concurrent_anthracycline_and_her2": false, "disclaimer": "Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.", "formula": "hfa_icos_her2", "formula_expression": "HFA-ICOS HER2 (Lyon 2020): very_high if heart_failure_or_cardiomyopathy or prior_trastuzumab_cardiotoxicity; else high if mi_or_cabg or stable_angina or severe_valvular_heart_disease or lvef_percent<50 or age_years>=80 or concurrent_anthracycline_and_her2 or medium_points>=5; else medium if medium_points 2-4; else low; medium_points = Medium 2 (2) + Medium 1 (1); Medium 2 = lvef 50-54, arrhythmia, elevated_troponin, elevated_bnp, age 65-79, prior_remote_anthracycline, prior_left_chest_or_mediastinal_rt; Medium 1 = hypertension, diabetes, ckd, anthracycline_before_her2 (if not concurrent), current_or_significant_smoker, obesity; cardiotoxicity_guide low <2%, medium 2-9%, high 10-19%, very_high >=20%", "high_present": false, "lvef_percent": 60, "max_score": 20, "medium_points": 0, "risk_level": "low", "score": 0, "very_high_present": false }, { "age_years": 50, "anthracycline_before_her2": false, "cardiotoxicity_guide": "<2%", "citation": { "authors": "Lyon AR, Dent S, Stanway S, et al.", "doi": "10.1002/ejhf.1920", "id": "lyon-2020", "pmid": "32458582", "source": "Eur J Heart Fail. 2020;22(11):1945-1960", "title": "Baseline cardiovascular risk assessment in cancer patients scheduled to receive cardiotoxic cancer therapies: a position statement and new risk assessment tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in collaboration with the International Cardio-Oncology Society" }, "components": [ { "factor": "heart_failure_or_cardiomyopathy", "points": 0, "present": false }, { "factor": "prior_trastuzumab_cardiotoxicity", "points": 0, "present": false }, { "factor": "mi_or_cabg", "points": 0, "present": false }, { "factor": "stable_angina", "points": 0, "present": false }, { "factor": "severe_valvular_heart_disease", "points": 0, "present": false }, { "factor": "lvef_lt_50", "points": 0, "present": false, "value": 60 }, { "factor": "age_ge_80", "points": 0, "present": false, "value": 50 }, { "factor": "concurrent_anthracycline_and_her2", "points": 0, "present": false }, { "factor": "lvef_50_54", "points": 0, "present": false, "value": 60 }, { "factor": "arrhythmia", "points": 0, "present": false }, { "factor": "elevated_troponin", "points": 0, "present": false }, { "factor": "elevated_bnp", "points": 0, "present": false }, { "factor": "age_65_79", "points": 0, "present": false, "value": 50 }, { "factor": "prior_remote_anthracycline", "points": 0, "present": false }, { "factor": "prior_left_chest_or_mediastinal_rt", "points": 0, "present": false }, { "factor": "hypertension", "points": 0, "present": false }, { "factor": "diabetes", "points": 0, "present": false }, { "factor": "ckd", "points": 0, "present": false }, { "factor": "anthracycline_before_her2", "points": 0, "present": false }, { "factor": "current_or_significant_smoker", "points": 0, "present": false }, { "factor": "obesity", "points": 0, "present": false } ], "concurrent_anthracycline_and_her2": false, "disclaimer": "Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.", "formula": "hfa_icos_her2", "formula_expression": "HFA-ICOS HER2 (Lyon 2020): very_high if heart_failure_or_cardiomyopathy or prior_trastuzumab_cardiotoxicity; else high if mi_or_cabg or stable_angina or severe_valvular_heart_disease or lvef_percent<50 or age_years>=80 or concurrent_anthracycline_and_her2 or medium_points>=5; else medium if medium_points 2-4; else low; medium_points = Medium 2 (2) + Medium 1 (1); Medium 2 = lvef 50-54, arrhythmia, elevated_troponin, elevated_bnp, age 65-79, prior_remote_anthracycline, prior_left_chest_or_mediastinal_rt; Medium 1 = hypertension, diabetes, ckd, anthracycline_before_her2 (if not concurrent), current_or_significant_smoker, obesity; cardiotoxicity_guide low <2%, medium 2-9%, high 10-19%, very_high >=20%", "high_present": false, "lvef_percent": 60, "max_score": 20, "medium_points": 0, "risk_level": "low", "score": 0, "very_high_present": false } ], "path": "/api/calc/hfa_icos_her2" }, "type": "json" } }, "schema": { "$schema": "https://json-schema.org/draft/2020-12/schema", "properties": { "input": { "additionalProperties": false, "properties": { "body": { "additionalProperties": false, "properties": { "items": { "items": { "properties": { "age_years": { "description": "Age in years (integer 18-100). Lyon 2020 exclusive bands: ≥80 is High; 65-79 is Medium 2 (2 points); younger than 65 does not score. Age 80 is High, not Medium 2.", "type": "integer" }, "anthracycline_before_her2": { "description": "Current regimen includes anthracycline before HER2-targeted therapy, sequential not concurrent (Lyon 2020 HER2 table Medium 1). true or false. Ignored for points when concurrent_anthracycline_and_her2 is true.", "type": "boolean" }, "arrhythmia": { "description": "Atrial fibrillation, atrial flutter, VT, or VF as assigned by the caller (Lyon 2020 HER2 table Medium 2). true or false. magent does not interpret the ECG.", "type": "boolean" }, "ckd": { "description": "Chronic kidney disease as assigned by the caller (Lyon 2020 HER2 table Medium 1). true or false.", "type": "boolean" }, "concurrent_anthracycline_and_her2": { "description": "Anthracycline and trastuzumab delivered concurrently on the current protocol (Lyon 2020 HER2 table footnote f; High). true or false. When true, anthracycline_before_her2 does not add Medium 1 points.", "type": "boolean" }, "current_or_significant_smoker": { "description": "Current or significant smoking history as assigned by the caller (Lyon 2020 HER2 table Medium 1). true or false.", "type": "boolean" }, "diabetes": { "description": "Diabetes mellitus as assigned by the caller (Lyon 2020 HER2 table Medium 1). true or false.", "type": "boolean" }, "elevated_bnp": { "description": "Elevated BNP or NT-proBNP as assigned by the caller (Lyon 2020 HER2 table Medium 2). true or false. magent does not assay natriuretic peptides.", "type": "boolean" }, "elevated_troponin": { "description": "Elevated troponin as assigned by the caller (Lyon 2020 HER2 table Medium 2). true or false. magent does not assay troponin.", "type": "boolean" }, "heart_failure_or_cardiomyopathy": { "description": "Heart failure or cardiomyopathy as assigned by the caller (Lyon 2020 HER2 table Very high). true or false.", "type": "boolean" }, "hypertension": { "description": "Hypertension as assigned by the caller (Lyon 2020 HER2 table Medium 1). true or false.", "type": "boolean" }, "lvef_percent": { "description": "Left-ventricular ejection fraction percent (integer 10-80) as assigned by the caller. <50 is High; 50-54 is Medium 2 (2 points); ≥55 does not score. magent does not measure LVEF.", "type": "integer" }, "mi_or_cabg": { "description": "Prior myocardial infarction or CABG as assigned by the caller (Lyon 2020 HER2 table High). true or false.", "type": "boolean" }, "obesity": { "description": "Obesity as assigned by the caller (Lyon 2020 HER2 table Medium 1). true or false. magent does not compute BMI.", "type": "boolean" }, "prior_left_chest_or_mediastinal_rt": { "description": "Prior left-chest or mediastinal radiotherapy as assigned by the caller (Lyon 2020 HER2 table Medium 2). true or false.", "type": "boolean" }, "prior_remote_anthracycline": { "description": "Prior remote anthracycline for a previous malignancy, not the current protocol (Lyon 2020 HER2 table footnote g; Medium 2). true or false.", "type": "boolean" }, "prior_trastuzumab_cardiotoxicity": { "description": "Prior trastuzumab cardiotoxicity as assigned by the caller (Lyon 2020 HER2 table Very high). true or false. magent does not review prior exposure.", "type": "boolean" }, "severe_valvular_heart_disease": { "description": "Severe valvular heart disease as assigned by the caller (Lyon 2020 HER2 table High). true or false.", "type": "boolean" }, "stable_angina": { "description": "Stable angina as assigned by the caller (Lyon 2020 HER2 table High). true or false.", "type": "boolean" } }, "required": [ "age_years", "lvef_percent", "heart_failure_or_cardiomyopathy", "prior_trastuzumab_cardiotoxicity", "mi_or_cabg", "stable_angina", "severe_valvular_heart_disease", "concurrent_anthracycline_and_her2", "arrhythmia", "elevated_troponin", "elevated_bnp", "prior_remote_anthracycline", "prior_left_chest_or_mediastinal_rt", "hypertension", "diabetes", "ckd", "anthracycline_before_her2", "current_or_significant_smoker", "obesity" ], "type": "object" }, "maxItems": 25, "minItems": 1, "type": "array" } }, "required": [ "items" ], "type": "object" }, "headers": { "additionalProperties": { "type": "string" }, "type": "object" }, "method": { "const": "POST", "type": "string" }, "type": { "const": "http", "type": "string" } }, "required": [ "type", "method" ], "type": "object" }, "output": { "properties": { "example": { "type": "object" }, "type": { "type": "string" } }, "required": [ "type" ], "type": "object" } }, "required": [ "input" ], "type": "object" } } }, "tags": [ "hfa-icos", "her2", "cardio-oncology", "trastuzumab", "calculator", "bazaar" ], "sourceHost": "api.magentlab.com", "lastUpdated": "2026-10-12T13:35:20.142Z", "quality": { "calls30d": 3, "uniquePayers30d": 1, "lastCalledAt": "2026-10-12T13:35:19.995Z" }, "metadata": { "serviceName": "magent", "extensions": { "bazaar": { "info": { "iconUrl": "https://api.magentlab.com/favicon.ico", "input": { "body": { "items": [ { "age_years": 50, "anthracycline_before_her2": false, "arrhythmia": false, "ckd": false, "concurrent_anthracycline_and_her2": false, "current_or_significant_smoker": false, "diabetes": false, "elevated_bnp": false, "elevated_troponin": false, "heart_failure_or_cardiomyopathy": false, "hypertension": false, "lvef_percent": 60, "mi_or_cabg": false, "obesity": false, "prior_left_chest_or_mediastinal_rt": false, "prior_remote_anthracycline": false, "prior_trastuzumab_cardiotoxicity": false, "severe_valvular_heart_disease": false, "stable_angina": false }, { "age_years": 50, "anthracycline_before_her2": false, "arrhythmia": false, "ckd": false, "concurrent_anthracycline_and_her2": false, "current_or_significant_smoker": false, "diabetes": false, "elevated_bnp": false, "elevated_troponin": false, "heart_failure_or_cardiomyopathy": false, "hypertension": false, "lvef_percent": 60, "mi_or_cabg": false, "obesity": false, "prior_left_chest_or_mediastinal_rt": false, "prior_remote_anthracycline": false, "prior_trastuzumab_cardiotoxicity": false, "severe_valvular_heart_disease": false, "stable_angina": false } ] }, "method": "POST", "type": "http" }, "output": { "example": { "count": 2, "items": [ { "age_years": 50, "anthracycline_before_her2": false, "cardiotoxicity_guide": "<2%", "citation": { "authors": "Lyon AR, Dent S, Stanway S, et al.", "doi": "10.1002/ejhf.1920", "id": "lyon-2020", "pmid": "32458582", "source": "Eur J Heart Fail. 2020;22(11):1945-1960", "title": "Baseline cardiovascular risk assessment in cancer patients scheduled to receive cardiotoxic cancer therapies: a position statement and new risk assessment tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in collaboration with the International Cardio-Oncology Society" }, "components": [ { "factor": "heart_failure_or_cardiomyopathy", "points": 0, "present": false }, { "factor": "prior_trastuzumab_cardiotoxicity", "points": 0, "present": false }, { "factor": "mi_or_cabg", "points": 0, "present": false }, { "factor": "stable_angina", "points": 0, "present": false }, { "factor": "severe_valvular_heart_disease", "points": 0, "present": false }, { "factor": "lvef_lt_50", "points": 0, "present": false, "value": 60 }, { "factor": "age_ge_80", "points": 0, "present": false, "value": 50 }, { "factor": "concurrent_anthracycline_and_her2", "points": 0, "present": false }, { "factor": "lvef_50_54", "points": 0, "present": false, "value": 60 }, { "factor": "arrhythmia", "points": 0, "present": false }, { "factor": "elevated_troponin", "points": 0, "present": false }, { "factor": "elevated_bnp", "points": 0, "present": false }, { "factor": "age_65_79", "points": 0, "present": false, "value": 50 }, { "factor": "prior_remote_anthracycline", "points": 0, "present": false }, { "factor": "prior_left_chest_or_mediastinal_rt", "points": 0, "present": false }, { "factor": "hypertension", "points": 0, "present": false }, { "factor": "diabetes", "points": 0, "present": false }, { "factor": "ckd", "points": 0, "present": false }, { "factor": "anthracycline_before_her2", "points": 0, "present": false }, { "factor": "current_or_significant_smoker", "points": 0, "present": false }, { "factor": "obesity", "points": 0, "present": false } ], "concurrent_anthracycline_and_her2": false, "disclaimer": "Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.", "formula": "hfa_icos_her2", "formula_expression": "HFA-ICOS HER2 (Lyon 2020): very_high if heart_failure_or_cardiomyopathy or prior_trastuzumab_cardiotoxicity; else high if mi_or_cabg or stable_angina or severe_valvular_heart_disease or lvef_percent<50 or age_years>=80 or concurrent_anthracycline_and_her2 or medium_points>=5; else medium if medium_points 2-4; else low; medium_points = Medium 2 (2) + Medium 1 (1); Medium 2 = lvef 50-54, arrhythmia, elevated_troponin, elevated_bnp, age 65-79, prior_remote_anthracycline, prior_left_chest_or_mediastinal_rt; Medium 1 = hypertension, diabetes, ckd, anthracycline_before_her2 (if not concurrent), current_or_significant_smoker, obesity; cardiotoxicity_guide low <2%, medium 2-9%, high 10-19%, very_high >=20%", "high_present": false, "lvef_percent": 60, "max_score": 20, "medium_points": 0, "risk_level": "low", "score": 0, "very_high_present": false }, { "age_years": 50, "anthracycline_before_her2": false, "cardiotoxicity_guide": "<2%", "citation": { "authors": "Lyon AR, Dent S, Stanway S, et al.", "doi": "10.1002/ejhf.1920", "id": "lyon-2020", "pmid": "32458582", "source": "Eur J Heart Fail. 2020;22(11):1945-1960", "title": "Baseline cardiovascular risk assessment in cancer patients scheduled to receive cardiotoxic cancer therapies: a position statement and new risk assessment tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in collaboration with the International Cardio-Oncology Society" }, "components": [ { "factor": "heart_failure_or_cardiomyopathy", "points": 0, "present": false }, { "factor": "prior_trastuzumab_cardiotoxicity", "points": 0, "present": false }, { "factor": "mi_or_cabg", "points": 0, "present": false }, { "factor": "stable_angina", "points": 0, "present": false }, { "factor": "severe_valvular_heart_disease", "points": 0, "present": false }, { "factor": "lvef_lt_50", "points": 0, "present": false, "value": 60 }, { "factor": "age_ge_80", "points": 0, "present": false, "value": 50 }, { "factor": "concurrent_anthracycline_and_her2", "points": 0, "present": false }, { "factor": "lvef_50_54", "points": 0, "present": false, "value": 60 }, { "factor": "arrhythmia", "points": 0, "present": false }, { "factor": "elevated_troponin", "points": 0, "present": false }, { "factor": "elevated_bnp", "points": 0, "present": false }, { "factor": "age_65_79", "points": 0, "present": false, "value": 50 }, { "factor": "prior_remote_anthracycline", "points": 0, "present": false }, { "factor": "prior_left_chest_or_mediastinal_rt", "points": 0, "present": false }, { "factor": "hypertension", "points": 0, "present": false }, { "factor": "diabetes", "points": 0, "present": false }, { "factor": "ckd", "points": 0, "present": false }, { "factor": "anthracycline_before_her2", "points": 0, "present": false }, { "factor": "current_or_significant_smoker", "points": 0, "present": false }, { "factor": "obesity", "points": 0, "present": false } ], "concurrent_anthracycline_and_her2": false, "disclaimer": "Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.", "formula": "hfa_icos_her2", "formula_expression": "HFA-ICOS HER2 (Lyon 2020): very_high if heart_failure_or_cardiomyopathy or prior_trastuzumab_cardiotoxicity; else high if mi_or_cabg or stable_angina or severe_valvular_heart_disease or lvef_percent<50 or age_years>=80 or concurrent_anthracycline_and_her2 or medium_points>=5; else medium if medium_points 2-4; else low; medium_points = Medium 2 (2) + Medium 1 (1); Medium 2 = lvef 50-54, arrhythmia, elevated_troponin, elevated_bnp, age 65-79, prior_remote_anthracycline, prior_left_chest_or_mediastinal_rt; Medium 1 = hypertension, diabetes, ckd, anthracycline_before_her2 (if not concurrent), current_or_significant_smoker, obesity; cardiotoxicity_guide low <2%, medium 2-9%, high 10-19%, very_high >=20%", "high_present": false, "lvef_percent": 60, "max_score": 20, "medium_points": 0, "risk_level": "low", "score": 0, "very_high_present": false } ], "path": "/api/calc/hfa_icos_her2" }, "type": "json" } }, "schema": { "$schema": "https://json-schema.org/draft/2020-12/schema", "properties": { "input": { "additionalProperties": false, "properties": { "body": { "additionalProperties": false, "properties": { "items": { "items": { "properties": { "age_years": { "description": "Age in years (integer 18-100). Lyon 2020 exclusive bands: ≥80 is High; 65-79 is Medium 2 (2 points); younger than 65 does not score. Age 80 is High, not Medium 2.", "type": "integer" }, "anthracycline_before_her2": { "description": "Current regimen includes anthracycline before HER2-targeted therapy, sequential not concurrent (Lyon 2020 HER2 table Medium 1). true or false. Ignored for points when concurrent_anthracycline_and_her2 is true.", "type": "boolean" }, "arrhythmia": { "description": "Atrial fibrillation, atrial flutter, VT, or VF as assigned by the caller (Lyon 2020 HER2 table Medium 2). true or false. magent does not interpret the ECG.", "type": "boolean" }, "ckd": { "description": "Chronic kidney disease as assigned by the caller (Lyon 2020 HER2 table Medium 1). true or false.", "type": "boolean" }, "concurrent_anthracycline_and_her2": { "description": "Anthracycline and trastuzumab delivered concurrently on the current protocol (Lyon 2020 HER2 table footnote f; High). true or false. When true, anthracycline_before_her2 does not add Medium 1 points.", "type": "boolean" }, "current_or_significant_smoker": { "description": "Current or significant smoking history as assigned by the caller (Lyon 2020 HER2 table Medium 1). true or false.", "type": "boolean" }, "diabetes": { "description": "Diabetes mellitus as assigned by the caller (Lyon 2020 HER2 table Medium 1). true or false.", "type": "boolean" }, "elevated_bnp": { "description": "Elevated BNP or NT-proBNP as assigned by the caller (Lyon 2020 HER2 table Medium 2). true or false. magent does not assay natriuretic peptides.", "type": "boolean" }, "elevated_troponin": { "description": "Elevated troponin as assigned by the caller (Lyon 2020 HER2 table Medium 2). true or false. magent does not assay troponin.", "type": "boolean" }, "heart_failure_or_cardiomyopathy": { "description": "Heart failure or cardiomyopathy as assigned by the caller (Lyon 2020 HER2 table Very high). true or false.", "type": "boolean" }, "hypertension": { "description": "Hypertension as assigned by the caller (Lyon 2020 HER2 table Medium 1). true or false.", "type": "boolean" }, "lvef_percent": { "description": "Left-ventricular ejection fraction percent (integer 10-80) as assigned by the caller. <50 is High; 50-54 is Medium 2 (2 points); ≥55 does not score. magent does not measure LVEF.", "type": "integer" }, "mi_or_cabg": { "description": "Prior myocardial infarction or CABG as assigned by the caller (Lyon 2020 HER2 table High). true or false.", "type": "boolean" }, "obesity": { "description": "Obesity as assigned by the caller (Lyon 2020 HER2 table Medium 1). true or false. magent does not compute BMI.", "type": "boolean" }, "prior_left_chest_or_mediastinal_rt": { "description": "Prior left-chest or mediastinal radiotherapy as assigned by the caller (Lyon 2020 HER2 table Medium 2). true or false.", "type": "boolean" }, "prior_remote_anthracycline": { "description": "Prior remote anthracycline for a previous malignancy, not the current protocol (Lyon 2020 HER2 table footnote g; Medium 2). true or false.", "type": "boolean" }, "prior_trastuzumab_cardiotoxicity": { "description": "Prior trastuzumab cardiotoxicity as assigned by the caller (Lyon 2020 HER2 table Very high). true or false. magent does not review prior exposure.", "type": "boolean" }, "severe_valvular_heart_disease": { "description": "Severe valvular heart disease as assigned by the caller (Lyon 2020 HER2 table High). true or false.", "type": "boolean" }, "stable_angina": { "description": "Stable angina as assigned by the caller (Lyon 2020 HER2 table High). true or false.", "type": "boolean" } }, "required": [ "age_years", "lvef_percent", "heart_failure_or_cardiomyopathy", "prior_trastuzumab_cardiotoxicity", "mi_or_cabg", "stable_angina", "severe_valvular_heart_disease", "concurrent_anthracycline_and_her2", "arrhythmia", "elevated_troponin", "elevated_bnp", "prior_remote_anthracycline", "prior_left_chest_or_mediastinal_rt", "hypertension", "diabetes", "ckd", "anthracycline_before_her2", "current_or_significant_smoker", "obesity" ], "type": "object" }, "maxItems": 25, "minItems": 1, "type": "array" } }, "required": [ "items" ], "type": "object" }, "headers": { "additionalProperties": { "type": "string" }, "type": "object" }, "method": { "const": "POST", "type": "string" }, "type": { "const": "http", "type": "string" } }, "required": [ "type", "method" ], "type": "object" }, "output": { "properties": { "example": { "type": "object" }, "type": { "type": "string" } }, "required": [ "type" ], "type": "object" } }, "required": [ "input" ], "type": "object" } } } }, "liveness": { "reliability": null }, "verified": false, "featured": false, "provider": { "host": "api.magentlab.com", "manifest_name": "api.magentlab.com", "source": "cdp-mirror", "source_manifest_url": "https://api.cdp.coinbase.com/platform/v2/x402/discovery/resources", "submitted_at": "2026-10-14T01:15:01.050Z" }, "exampleResponse": { "example": {}, "type": "string" } }